Congenital disorders of glycosylation and infantile epilepsy
Hsiu-Fen Lee1, Ching-Shiang Chi2
1Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, 145, Xingda Rd., Taichung 402, Taiwan; Division of Pediatric Neurology, Children's Medical Center, Taichung Veterans General Hospital, 1650, Taiwan Boulevard Sec. 4, Taichung 407, Taiwan.
Insights
Congenital disorders of glycosylation (CDG) are rare genetic conditions affecting protein and lipid pathways. This review highlights CDG-related epilepsy in infants and proposes early diagnostic strategies for families.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Congenital disorders of glycosylation (CDG) are rare inherited metabolic diseases impacting protein and lipid glycosylation.
- These disorders typically manifest in infancy with a range of symptoms.
- Epilepsy is a frequent and often initial symptom in individuals with CDG.
Purpose of the Study:
- To review the clinical and electroencephalographic features of epilepsy in CDG.
- To provide a systematic approach for earlier diagnosis of CDG in infants with epilepsy.
- To discuss genetic counseling implications for families affected by CDG.
Main Methods:
- Literature review of CDG and infantile epilepsy.
- Analysis of clinical manifestations and EEG findings.
- Development of a tiered diagnostic strategy.
Main Results:
- CDG-associated epilepsies often present in infancy, are frequently drug-resistant, and commonly comorbid with developmental and behavioral issues.
- Specific clinical and EEG patterns can suggest CDG in infants with epilepsy.
- Early identification facilitates timely intervention and genetic counseling.
Conclusions:
- Infantile epilepsy is a significant manifestation of CDG, necessitating early recognition.
- A structured diagnostic approach can improve the identification of CDG.
- Prompt diagnosis and genetic counseling are crucial for managing CDG and supporting affected families.
Abstract:
Congenital disorders of glycosylation (CDG) are a group of rare inherited metabolic disorders caused by defects in various defects of protein or lipid glycosylation pathways. The symptoms and signs of CDG usually develop in infancy. Epilepsy is commonly observed in CDG individuals and is often a presenting symptom. These epilepsies can present across the lifespan, share features of refractoriness to antiseizure medications, and are often associated with comorbid developmental delay, psychomotor regression, intellectual disability, and behavioral problems. In this review, we discuss CDG and infantile epilepsy, focusing on an overview of clinical manifestations and electroencephalographic features. Finally, we propose a tiered approach that will permit a clinician to systematically investigate and identify CDG earlier, and furthermore, to provide genetic counseling for the family.
More Related Videos
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Proteoglycans
Lysosomal Hydrolases
